Dynamic changes in three biomarkers predict early-stage hepatocellular carcinoma in patients with chronic hepatitis B receiving antiviral therapy

被引：0
|
作者：
Qianyu Zhu
Jialing Zhou
Hongyi Li
Hui Wang
Jiangbo Ren
Shujie Sun
Miaoran Yang
Shanshan Wu
Ming Cao
Kaixiang Wang
Hong You
Hong Ma
机构：
[1] Beijing Friendship Hospital,Liver Research Center
[2] Capital Medical University,Molecular Biology Laboratory
[3] National Clinical Research Center for Digestive Diseases,undefined
[4] Baoding People’s Hospital,undefined
来源：
Journal of Cancer Research and Clinical Oncology | 2023年 / 149卷
关键词：
Biomarker; Hepatocellular carcinoma; Liver cirrhosis; Antiviral agent; Diagnosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：12691 / 12701
页数：10
相关论文
共 50 条
  • [41] RISK ASSESSMENT OF HEPATOCELLULAR CARCINOMA IN CHRONIC HEPATITIS B PATIENTS WITH LONG-TERM ANTIVIRAL THERAPY
    Chung, K. S.
    Lee, H. W.
    Kim, D. Y.
    Kim, B. K.
    Kim, S. U.
    Park, J. Y.
    Han, K. -H.
    Ahn, S. H.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S517 - S517
  • [42] Impact of antiviral therapy on risk prediction model for hepatocellular carcinoma development in patients with chronic hepatitis B
    Chon, Hye Yeon
    Lee, Jae Seung
    Lee, Hye Won
    Chun, Ho Soo
    Kim, Beom Kyung
    Park, Jun Yong
    Kim, Do Young
    Ahn, Sang Hoon
    Kim, Seung Up
    HEPATOLOGY RESEARCH, 2021, 51 (04) : 406 - 416
  • [43] Undertreatment of Patients With Early-Stage Hepatocellular Carcinoma
    Schulick, Richard D.
    ARCHIVES OF SURGERY, 2010, 145 (12) : 1163 - 1164
  • [44] CHRONIC HEPATITIS B PATIENTS TREATED WITH ORAL ANTIVIRAL THERAPY HAVE STILL HIGHER RISK FOR HEPATOCELLULAR CARCINOMA COMPARED TO INACTIVE STAGE PATIENTS
    Cho, J-Y.
    Paik, Y-H.
    Sohn, W.
    Cho, H. C.
    Gwak, G-Y.
    Choi, M. S.
    Lee, J. H.
    Koh, K. C.
    Paik, S. W.
    Yoo, B. C.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S252 - S252
  • [45] Effect of antiviral treatment on the risk of hepatocellular carcinoma in patients with chronic hepatitis B
    Tziomalos, Konstantinos
    WORLD JOURNAL OF HEPATOLOGY, 2010, 2 (03) : 91 - 93
  • [46] Hepatocellular carcinoma in chronic hepatitis B patients on antiviral treatment with virological suppression
    Ghaly, S.
    Bu, K.
    Yan, K.
    Choo, L.
    George, J.
    Chu, F.
    Strasser, S.
    Zekry, A.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 : 51 - 51
  • [47] Long-Term Prediction Model for Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Receiving Antiviral Therapy: Based on Data from Korean Patients
    Lee, Ji Hun
    Shin, Seung Kak
    Kang, Seong Hee
    Kim, Tae Hyung
    Yim, Hyung Joon
    Yim, Sun Young
    Lee, Young-Sun
    Jung, Young Kul
    Kim, Ji Hoon
    Seo, Yeon Seok
    Yeon, Jong Eun
    Kwon, Oh Sang
    Um, Soon Ho
    Byun, Kwan Soo
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (22)
  • [48] Effect of antiviral treatment on the risk of hepatocellular carcinoma in patients with chronic hepatitis B
    Konstantinos Tziomalos
    World Journal of Hepatology, 2010, 2 (03) : 91 - 93
  • [49] Direct-acting Antiviral Therapy Improves the Outcome of Chronic Hepatitis C/intermediate-stage B Hepatocellular Carcinoma Patients
    Shao, Changhan
    Shao, Paul P.
    Chen, Wei-Ting
    Lin, Cheng-Chun
    Lin, Wey-Ran
    Yeh, Chau-Ting
    ANTICANCER RESEARCH, 2021, 41 (04) : 2007 - 2016
  • [50] Clinical Course of Patients with Decompensated Chronic Hepatitis B Receiving Antiviral Therapy
    Ahn, Sena Bong
    Jun, Da Won
    Sohn, Joo Hyun
    Oh, Hyun Woo
    Jeong, Jae Yoon
    Lee, Hyo Young
    Kang, Bo-Kyeong
    Kim, Mimi
    Kim, Jae Ha
    Park, Jin Hwa
    Koh, Dong Hee
    Yoon, Byung Chu
    HEPATOLOGY, 2018, 68 : 1236A - 1236A
12345